Japan
Medicine & Life Sciences
100%
Personality
Medicine & Life Sciences
64%
Colorectal Neoplasms
Medicine & Life Sciences
40%
Depression
Medicine & Life Sciences
36%
Stomach Neoplasms
Medicine & Life Sciences
34%
Neoplasms
Medicine & Life Sciences
32%
Single Nucleotide Polymorphism
Medicine & Life Sciences
31%
kalinin
Medicine & Life Sciences
27%
Shinmura, K. ,
Kato, H. ,
Kawasaki, H. ,
Hariyama, T. ,
Yoshimura, K. ,
Tsuchiya, K. ,
Watanabe, H. ,
Ohta, I. ,
Asahina, E. ,
Sumiyoshi, F. ,
Hamada, K. ,
Kawanishi, Y. ,
Kawase, A. ,
Funai, K. &
Sugimura, H. ,
2023 2月 1 ,
In: Laboratory investigation; a journal of technical methods and pathology. 103 ,
2 ,
p. 100007 1 p. 研究成果: Article › 査読
Cilia
100%
Carcinoid Tumor
97%
Small Cell Lung Carcinoma
95%
Non-Small Cell Lung Carcinoma
76%
Lung
45%
Ishida, T. ,
Kuwahara, Y. ,
Shibahashi, K. ,
Okura, Y. ,
Sugiyama, K. ,
Yoshimura, K. ,
Hamabe, Y. ,
Mimura, M. ,
Suzuki, T. &
Uchida, H. ,
2021 6月 ,
In: Injury. 52 ,
6 ,
p. 1390-1395 6 p. 研究成果: Article › 査読
Preexisting Condition Coverage
100%
Traffic Accidents
96%
Mental Disorders
67%
Cohort Studies
56%
Retrospective Studies
56%
Takao, Y. ,
Figueroa, E. ,
Berna, K. F. J. ,
Jo, Y. ,
Kissane, L. A. ,
Yoshimura, K. ,
Tranter, R. &
Porter, R. J. ,
2021 12月 ,
In: Health and Quality of Life Outcomes. 19 ,
1 , 163.
研究成果: Article › 査読
Patient Health Questionnaire
68%
Depression
64%
Health Care Outcome Assessment
35%
Online Systems
31%
Japan
18%
Hirata, T. ,
Arai, Y. ,
Yuasa, S. ,
Abe, Y. ,
Takayama, M. ,
Sasaki, T. ,
Kunitomi, A. ,
Inagaki, H. ,
Endo, M. ,
Morinaga, J. ,
Yoshimura, K. ,
Adachi, T. ,
Oike, Y. ,
Takebayashi, T. ,
Okano, H. &
Hirose, N. ,
2020 12月 1 ,
In: Nature communications. 11 ,
1 , 3820.
研究成果: Article › 査読
biomarkers
100%
albumins
93%
Serum Albumin
77%
mortality
70%
Biological Marker
67%
Uno, S. ,
Asakura, T. ,
Morimoto, K. ,
Yoshimura, K. ,
Uwamino, Y. ,
Nishimura, T. ,
Hoshino, Y. &
Hasegawa, N. ,
2020 10月 9 ,
In: BMC Pulmonary Medicine. 20 ,
1 , 262.
研究成果: Article › 査読
Insurance Claim Review
100%
Comorbidity
54%
Data Analysis
52%
Prostatic Neoplasms
23%
Lung Neoplasms
23%